- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Dr. Agarwal's Health Care board approved robust Q3 & 9M FY26 consolidated results. Q3 Total Income grew 21.9% YoY to ₹540 Cr, PAT jumped 54.5% to ₹44 Cr. 9M Income hit ₹1,548 Cr, PAT ₹118 Cr. Company also greenlit a new Ethiopia subsidiary; Idearx no longer an associate.